FMOC-L-Phenylalanine structure
|
Common Name | FMOC-L-Phenylalanine | ||
---|---|---|---|---|
CAS Number | 35661-40-6 | Molecular Weight | 387.428 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 620.1±50.0 °C at 760 mmHg | |
Molecular Formula | C24H21NO4 | Melting Point | 180-187 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 328.8±30.1 °C |
Use of FMOC-L-PhenylalanineFmoc-Phe-OH is a phenylalanine derivative[1]. |
Name | FMOC-L-Phenylalanine |
---|---|
Synonym | More Synonyms |
Description | Fmoc-Phe-OH is a phenylalanine derivative[1]. |
---|---|
Related Catalog | |
In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 620.1±50.0 °C at 760 mmHg |
Melting Point | 180-187 °C(lit.) |
Molecular Formula | C24H21NO4 |
Molecular Weight | 387.428 |
Flash Point | 328.8±30.1 °C |
Exact Mass | 387.147064 |
PSA | 75.63000 |
LogP | 5.41 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.633 |
Storage condition | 2~8°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S22-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2924299090 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.
Cancer Sci. 106 , 747-56, (2015) L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherap... |
|
In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel.
Pharm. Res. 32 , 3087-101, (2015) The objective of this work was to compare the efficacy of self-assembling cyclic and linear RGD peptide amphiphiles as carriers for delivering paclitaxel to αvβ3 integrin overexpressing tumors.Linear ... |
|
Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model.
Sci. Rep. 4 , 6777, (2014) Amyloid-β (Aβ) is one of the few neuropathological biomarkers associated with transporters of the blood-brain barrier (BBB). Despite the well-characterized clinical indication of decreasing Aβ levels ... |
Fmoc-L-Phc-OH |
N-FMOC-PHE-OH |
EINECS 252-661-1 |
L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- |
N-Fmoc-(S)-phenylalanine |
FMOC-L-PHE-OH |
FMOC-L-PHE |
N-Fmoc-L-Phe-OH |
MFCD00037128 |
9-fluorenylmethyloxycarbonyl-Phe-OH |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid |
N-FMOC-L-PHE |
N-Fmoc-L-phenylalanine |
FMOC-PHENYLALANINE |
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-phenylalanine |
Fmoc-Phe-OH |
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-3-phenyl-L-alanine |
N-9-Fmoc-L-phenylglycine |
FMOC-PHE |
N-Fmoc-Phe-OH ( N-Fmoc-L-phenylalanine) |